SLC26A3 and cancer: For example, proteins with CLD ≥ 1 appear differentially expressed in an average of 2.4 cancer types, which is significantly higher than for proteins with CLD ≥ 0 (1.96 cancer types, p-value < 2.2 × 10-16), but significantly lower than for proteins with CLD ≥ 20 (4.4 cancer types, p-value < 2.2 × 10-16).